![Dawn Schottlandt](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dawn Schottlandt
Contatto Relazioni con gli Investitori presso
GERON CORPORATION
Profilo
Dawn Schottlandt is Senior VP-Corporate Affairs & Investor Relations at Geron Corp.
since 2025.
Formerly, Ms. Schottlandt was VP-Investor Relations & Corporate Communications at Chiasma, Inc. from 2019 to 2020 and VP-Investor Relations & Corporate Communications at ArQule, Inc. from 2015 to 2018.
Education includes undergraduate studies at Boston College.
Posizioni attive di Dawn Schottlandt
| Società | Posizione | Inizio |
|---|---|---|
| GERON CORPORATION | Contatto Relazioni con gli Investitori | 01/10/2025 |
Precedenti posizioni note di Dawn Schottlandt
| Società | Posizione | Fine |
|---|---|---|
| CHIASMA, INC. | Contatto Relazioni con gli Investitori | 01/07/2020 |
| ARQULE, INC. | Contatto Relazioni con gli Investitori | 01/01/2018 |
Formazione di Dawn Schottlandt
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
24
Relazioni di 1° grado
4
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
Geron Corp.
 Geron Corp. BiotechnologyHealth Technology Discovers and develops therapeutic products for cancer | Health Technology |
ArQule, Inc.
 ArQule, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that researches and develops therapeutics to treat cancers & rare diseases | Health Technology |
Chiasma, Inc.
 Chiasma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops treatments for rare and serious chronic disease | Health Technology |
Boston College
 Boston College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
